Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.
NSIC signed MoU with LG Electronics to set up a Centre of Excellence for MSME Sector In this endeavour, the LG Electronics and Electronics Sector Skills Council of India (ESSCI) will set up a "Centre of Excellence" at NSIC - Technical Services Centre.
EXAMIANS